Tanycyte-Derived Lactate Activates Astrocytic HCAR1 to Modulate Glutamatergic Signaling and POMC Neuron Excitability

For decades, the intricate mechanisms governing appetite and satiety have been largely attributed to the sophisticated communication networks of neurons, the brain’s principal electrical signaling cells. However, a groundbreaking study published on April 6, 2026, in the prestigious journal Proceedings of the National Academy of Sciences is fundamentally reshaping this understanding. Researchers from the University of Concepción in Chile, in collaboration with colleagues at the University of Maryland, have unveiled a novel signaling pathway within the hypothalamus, the brain’s command center for hunger and fullness, that prominently features astrocytes. These cells, long relegated to a supporting role for neurons, are now emerging as active and crucial regulators of our eating behaviors, potentially paving the way for revolutionary new treatments for obesity and eating disorders.

A Paradigm Shift in Brain Communication

The prevailing scientific dogma has long posited neurons as the sole arbiters of complex brain functions, including the regulation of energy balance. This view, while rooted in substantial evidence, has increasingly been challenged by discoveries highlighting the multifaceted roles of glial cells, particularly astrocytes. These star-shaped cells, the most abundant cell type in the brain, were traditionally considered mere housekeepers, providing structural support, supplying nutrients, and clearing waste products for neurons. The new research, however, firmly places astrocytes at the forefront of appetite control, demonstrating their direct involvement in interpreting metabolic signals and relaying information that influences our decisions about when to eat and when to stop.

"There’s a pervasive tendency to immediately associate brain function with neurons," explained Ricardo Araneda, a professor in the Department of Biology at the University of Maryland and a corresponding author on the study. "But our findings compellingly demonstrate that astrocytes, which we historically viewed as purely secondary support cells, are actively participating in how our brains regulate food intake. This research significantly alters our conceptualization of these fundamental communication circuits within the brain."

Unraveling the Glucose-Sensing Pathway

The intricate process begins with specialized cells known as tanycytes, which are strategically positioned lining a fluid-filled cavity deep within the brain. These unique cells act as sophisticated sensors, continuously monitoring glucose levels in the cerebrospinal fluid. Glucose, the primary fuel source for the body, provides a direct indicator of nutritional status.

Following a meal, as the digestive system breaks down food and releases nutrients into the bloodstream, glucose levels rise. Tanycytes are highly responsive to these fluctuations. Upon detecting elevated glucose, they initiate a cascade of events. They metabolize the sugar and, in doing so, release lactate, a byproduct of this metabolic process, into the surrounding brain tissue. This released lactate then acts as a crucial signaling molecule, interacting with neighboring astrocytes and initiating the next critical phase of communication in the appetite regulation pathway.

"Previously, the scientific consensus was that lactate produced by tanycytes directly communicated with the neurons responsible for appetite control," Araneda elaborated. "However, our investigation has revealed an unexpected intermediary in this crucial conversation: astrocytes."

Astrocytes: More Than Just Support

The study meticulously details how astrocytes, empowered by this lactate signal, transition from passive bystanders to active participants in neural signaling. The researchers identified a specific receptor on the surface of astrocytes, known as HCAR1 (Hydroxycarboxylic Acid Receptor 1). This receptor is exquisitely sensitive to lactate. When lactate molecules bind to HCAR1, they trigger a conformational change in the astrocyte, leading to its activation.

Once activated, astrocytes release glutamate, a major excitatory neurotransmitter in the central nervous system. This glutamate signal is then transmitted to specific neurons within the hypothalamus. Crucially, these targeted neurons are part of a circuit that suppresses appetite, ultimately leading to the physiological sensation of fullness and satiety.

"The sheer complexity of this interaction was astonishing," Araneda remarked. "To simplify, we’ve discovered a sophisticated dialogue: tanycytes communicate with astrocytes, and it is the astrocytes that then relay the message to the neurons that govern our feelings of hunger and fullness."

A Chain Reaction of Neural Activation

To validate their findings, the research team employed sophisticated experimental techniques, including optogenetics and calcium imaging, in animal models. In one pivotal experiment, scientists precisely introduced glucose into a single tanycyte while simultaneously observing the activity of nearby astrocytes. The results were striking: even this highly localized metabolic change was sufficient to trigger a widespread activation of multiple surrounding astrocytes. This observation powerfully illustrates how metabolic signals can propagate through the brain’s complex cellular network, influencing a broader neural response.

"We also observed what appears to be a dual regulatory effect," Araneda noted. "The hypothalamus houses two distinct populations of neurons that have opposing effects on appetite: those that promote hunger and those that suppress it. Our findings suggest that lactate, acting through astrocytes, may exert influence on both simultaneously. It appears to activate the neurons that promote fullness via the astrocytic pathway, while potentially also having a direct or indirect effect on quieting the neurons that stimulate hunger. This dual action could provide a more finely tuned control over energy balance."

Implications for Metabolic Health and Beyond

While the foundational research was conducted using animal models, the presence of both tanycytes and astrocytes is conserved across all mammalian species, including humans. This evolutionary continuity strongly suggests that the same intricate mechanism for appetite regulation is likely operative in humans, holding significant implications for public health.

The research team has outlined a clear roadmap for future investigations. The immediate next step involves testing whether modulating the activity of the HCAR1 receptor in astrocytes can directly influence eating behavior in preclinical models. This line of inquiry is considered essential before any potential therapeutic interventions can be seriously contemplated.

Currently, no pharmaceutical agents directly target this newly identified astrocytic pathway. However, Araneda expressed considerable optimism about its therapeutic potential. "We now have identified a novel biological mechanism that offers a distinct avenue for intervention," he stated. "The possibility of targeting astrocytes or, more specifically, the HCAR1 receptor presents a promising new direction for developing treatments for appetite-related conditions. This could potentially complement existing therapies, such as GLP-1 receptor agonists like Ozempic, and significantly improve the quality of life for individuals suffering from obesity, anorexia nervosa, bulimia nervosa, and other complex eating disorders."

A Decade of Dedicated Collaboration

This groundbreaking discovery is the culmination of nearly ten years of sustained and intensive collaborative research. The partnership between Professor Araneda’s laboratory at the University of Maryland and the laboratory of María de los Ángeles García-Robles at the University of Concepción, who served as the project’s principal investigator, has been instrumental. Sergio López, the study’s lead author, is a doctoral student who benefited from a dual mentorship by both researchers. His eight-month research visit to the University of Maryland was pivotal in carrying out many of the key experiments that underpin this study.

The comprehensive findings are detailed in the paper titled "Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability," published in the Proceedings of the National Academy of Sciences on April 6, 2026.

The research was generously supported by funding from Chile’s National Fund for Scientific and Technological Development, the Millennium Institute of Neuroscience in Valparaíso, and the U.S. National Institutes of Health (Award No. R01AG088147A). These organizations play a vital role in fostering cutting-edge scientific inquiry that has the potential to profoundly impact human health. It is important to note that the views expressed in this article are those of the researchers and do not necessarily reflect the official positions of the funding bodies.